Pausing certain arthritis drugs after COVID-19 vaccination raises flare risk without improving antibody response

For patients with inflammatory arthritis, holding definite disease-modifying antirheumatic drugs (DMARDs), namely prime biologic oregon Janus kinase inhibitor (JAKi) therapies, for 2 weeks astatine the clip of a supplemental COVID-19 vaccine dose does not heighten humoral immunogenicity, according to a survey published online Oct. 5 successful JAMA Internal Medicine.